Baxter Enters Bone Fusion Market Via $330 Million ApaTech Acquisition
This article was originally published in The Gray Sheet
Executive Summary
Baxter will gain an immediate entry into the bone fusion market through its acquisition of Actifuse bone graft maker ApaTech for up to $330 million, including milestone payments, the firm says